Biocides and PMC
Evaluation of substances and products for placing and making them available on the market according to Reg (UE) 528/2012 - the activity aims to guarantee the safe and sustainable use of substances and biocidal products and their placing on the market through procedures and timelines evaluation established by European Regulations and national Directives for the protection of the consumer, the operator and the environment.
Biocidal Active substances: Dossiers regarding the the application for approval of biocidal active substances are evaluated and the relative technical reports are subnìmitted to ECHA and to the MSs for bi-trilateral discussion and followed through all the steps up to the final approval/non-approval decisions, including discussion at the BPC Committee (Biocidal Products Committee) and at the CA (Competent Authority) meetings.
Biocidal products: Management of dossiers of biocidal products regarding different types of applications for authorization, submitted through the European Register for Biocidal Products (R4BP3); interaction with the other EU countries in case of multiple interested states (multiple recognition in parallel or in sequence). Evaluation of the dossiers submitted for the authorization and follow up through the final decisions of approval/non-approval, including multilateral discussion and, if the case, participating to Coordination Group meetings.
CLH: preparation of harmonized classification reports for biocidal and phytosanitary substances as dossier submitters and participation in ECHA and EFSA works, in particular on endocrine disruptors but also on APCP, EFF, HH and ENV WGs.
